Select Page
What if you could predict your risk of cancer before you actually have it?

Innovations in healthcare technology give us all hope that we will be able to beat cancer in our lifetime. The question is what technology, for what type of cancer, and when will it be available?

There is technology that predicts who is at risk for developing cancer before they actually have cancer.

And it is available now.

Why early detection matters

Early detection has been demonstrated to improve outcomes and save lives.

Personalized medicine is the next step to improve outcomes especially if you are at risk of developing cancer. It may also provide peace of mind if you have a minimal risk of disease progression.

Please talk to your Healthcare Professional if you have any questions about your health.

Click on the cancer type for more information

Are you at risk for developing

Oral Cancer

The 5-year survival rate is approximately 50%* due to the late stage diagnosis of oral cancer. It progresses without pain or symptoms. As a result of late diagnosis, patients may have to cope with facial disfigurement, the inability to talk or eat normally, pain, dry mouth, and the loss of taste.

You deserve better and we believe we can help.
Click for more info

Are you at risk for

Thyroid Cancer
Under Research & Development

Are you at risk for

Breast Cancer
Under Research & Development

Are you at risk for

Prostate Cancer
Under Research & Development
Proteocyte AI  is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer.

References:

*Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-386.